Filing Details

Accession Number:
0001179110-12-009400
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-31 19:27:32
Reporting Period:
2012-05-29
Filing Date:
2012-05-31
Accepted Time:
2012-05-31 19:27:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1080014 Theravance Inc THRX Pharmaceutical Preparations (2834) 943265960
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1318005 W Michael Aguiar Theravance, Inc.
901 Gateway Boulevard
South San Francisco CA 94080
Sr Vp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-05-29 20,000 $22.29 157,924 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $21.99 to $22.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.